Streetbeat News

Stock Prices

IAUX

i-80 Gold shares rose following the announcement of Richard Young as the new CEO.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 11:51 am

BRCC

CPSH

FLGC

The article highlights recent insider transactions in penny stocks, focusing on CPS Technologies, Flora Growth, and BRC Inc. Executives from these companies have made significant share purchases, indicating confidence in their respective companies' prospects.

Portfolio Pulse from Avi Kapoor

September 18, 2024 | 11:47 am

APLT

Applied Therapeutics shares rose after the FDA announced that an advisory committee meeting is no longer required for the company.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 11:42 am

CLVT

Clarivate Plc (NYSE:CLVT) has launched the Primo Research Assistant, a generative AI-powered library discovery solution, boosting academic integrity and discovery. This development has led to a premarket increase in CLVT shares.

Portfolio Pulse from Lekha Gupta

September 18, 2024 | 11:41 am

MSTR

Michael Saylor, Executive Chairman of MicroStrategy, remains bullish on Bitcoin, predicting it could reach $13 million by 2045. He emphasizes Bitcoin's potential as a store of value and expects more companies to allocate reserves to Bitcoin. MicroStrategy's stock has surged 964% since 2020, reflecting its Bitcoin strategy.

Portfolio Pulse from Khyathi Dalal

September 18, 2024 | 11:38 am

ELF

FAMI

The article highlights two oversold stocks in the consumer staples sector, Farmmi Inc (NASDAQ:FAMI) and e.l.f. Beauty Inc (NYSE:ELF), which present potential buying opportunities. Both stocks have experienced significant price declines and have RSI values indicating they are oversold.

Portfolio Pulse from Avi Kapoor

September 18, 2024 | 11:23 am

TGTX

TG Therapeutics presented updated data from the ENHANCE Phase 3b trial evaluating BRIUMVI (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis. This update could influence investor sentiment towards TG Therapeutics.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 11:21 am

MIRA

MIRA Pharmaceuticals has announced significant progress in the clinical development planning for its novel oral ketamine analog. This development is a key milestone for the company as it advances its pharmaceutical innovations.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 11:13 am

GIS

General Mills anticipates gradual improvement in volume trends for its categories in fiscal 2025, although full-year category dollar growth is expected to fall short of the company's long-term growth projections.

Portfolio Pulse from Nabaparna Bhattacharya

September 18, 2024 | 11:08 am

APLT

The FDA has informed Applied Therapeutics that an advisory committee meeting is no longer required for their product. This could expedite the approval process, potentially impacting the company's stock positively.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 11:07 am